Publications found:
73,128
Sort by:
Indian Diagnostic Services Market Outlook 2020
US$ 1,000.00
... Indian Diagnostic Services Market Outlook 2020”, the diagnostic services market is expected to continue growing at 27.5% for next five years. This growth is likely to be driven by improving healthcare facilities, medical diagnostic ...
May 2016
120 pages
Global Artificial Casings Market Outlook: 2016-2021
US$ 4,175.00
... in the global artificial casings market? What are the burning issues of the global artificial casings market? Who are the major players in the global artificial casings market and What share of the market do they ...
May 2016
136 pages
Market Report for PET Imaging in Japan
US$ 9,020.00
... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the Japan market Current Japan healthcare system and reimbursement for PET imaging Market evolution and ...
May 2016
72 pages
Market Report for PET Imaging in the USA
US$ 6,400.00
... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the USA market Current USA healthcare system and reimbursement for PET imaging Market evolution ...
May 2016
139 pages
Market Report for PET Imaging in Top 5 EU Markets
US$ 16,540.00
... Swan, an introduction on PET imaging is given, as well as information on: The utilization of PET and the development of the PET modality over time in the T5 EU markets Current T5 EU healthcare systems and their reimbursement schemes for PET imaging Market evolution ...
May 2016
157 pages
Epiomic Epidemiology Series: Bladder Cancer Forecast in 18 Major Markets 2016-2026
US$ 6,382.00
... Occupation Bladder infections Bladder stones Family history of bladder cancer This report is built using data and information sourced from the proprietary Epiomic patient ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data ...
May 2016
66 pages
Customer Experience (CX) in Physician and HCP Engagement
US$ 695.00
... physician’s good customer experience is your biggest asset! Positive customer engagement with healthcare professionals (HCP) builds loyalty to your brands ... initiatives fail to engage physicians and HCPs? Wider support: How can stakeholders work with pharma to create a mutually beneficial customer experience? Evaluation: What ...
May 2016
-
NPS+ Asthma/COPD (EU5)
US$ 2,495.00
Satisfaction survey: One brand dominates EU5 Asthma/COPD market. Can your brand compete? Which asthma/COPD brand scored twice as high as its closest competitor ... Loyalty Issues NPS+ asthma/COPD (EU5) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn: How satisfied the asthma/COPD market is. How ...
May 2016
-
NPS+ Asthma/COPD (US)
US$ 2,495.00
... to Key Questions about Asthma/COPD Treatments Advair (fluticasone propionate/salmeterol; GSK): Advair and Symbicort have similar NPS scores. Which brand has ... Loyalty Issues NPS+ asthma/COPD (US) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn How satisfied the asthma/COPD market is. How ...
May 2016
-
Building Effective Health Economic Outcomes Research (HEOR) Teams
US$ 695.00
... to build an effective health economic and outcomes research team Health Economic and Outcomes Research (HEOR) teams play a critical market access role from refining clinical research and building a brand ... , Global Outcomes & Epidemiology within a top 50 global pharmaceutical manufacturer A Health Economics Director, Europe, within a top 50 global pharmaceutical manufacturer A Vice President, Health Economics and Outcomes Research ...
May 2016
-
Epiomic Epidemiology Series: Dysmenorrhea Forecast in 21 Major Markets 2016-2026
US$ 6,382.00
... of dysmenorrhea Early age at menarche Nulliparity Exercise level / fitness This report is built using data and information sourced from the proprietary Epiomic ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
May 2016
54 pages
Healthcare Mobility Solutions - Global Market Outlook (2015-2022)
US$ 4,150.00
... market growth. Expansion of healthcare industry in emerging regions such as Asia Pacific acts as opportunity for healthcare mobility solution market. In enterprise solution, patient care management segment ... time. North America accounted for the largest share of the healthcare mobility solutions market during the forecast period due to increasing adoption of gadgets ...
May 2016
170 pages
Stem Cell Therapy - Global Market Outlook (2015-2022)
US$ 4,150.00
... to advancements in stem cell therapy and continuous R & D activities on stem cells. Whereas, Asia Pacific is likely to witness highest growth on account of favourable government policies, increasing adoption of stem cell therapy and rising population in China and India. Some of the key players in stem cell therapy market include Aastrom Biosciences ...
May 2016
139 pages
Vascular Stents - Global Market Outlook (2015-2022)
US$ 4,150.00
... Global Vascular Stents Market is accounted for $8.21 billion in 2015 and is expected to reach $11.6 billion by 2022 growing at a CAGR of 5.18% from 2015 to 2022. Growing recognition for vascular stents ... market for global vascular stents market over the forecast period due to reduced cost of surgeries for healthcare treatments. Some of the key players in this market ...
May 2016
168 pages
Market Access Impact: Growth Hormone Deficiency (EU5)
US$ 4,995.00
... US. Endocrinologists in both markets most often prescribe the same three leading brands. Market Access Impact: GHD explores key issues affecting Growth Hormone manufacturers. You’ll learn: How barriers affect market access: What brands do doctors ...
May 2016
-
Market Access Impact: Growth Hormone Deficiency (US)
US$ 4,995.00
... . Endocrinologists in both markets most often prescribe the same three leading brands. Market Access Impact: GHD explores key issues affecting Growth Hormone manufacturers. You’ll learn: How barriers affect market access: What brands do doctors ...
May 2016
-
Medical Affairs Reputations: HIV (EU5)
US$ 5,995.00
... in Medical Affairs Reputations: HIV. You’ll learn how infectious disease specialists rate the teams for 8 major HIV treatments, whether ... medical affairs services most important to doctors. European doctors more likely to prefer frequent interactions: 50% of EU5 doctors prefer to interact with medical affairs ...
May 2016
-
Medical Affairs Reputations: HIV (US)
US$ 5,995.00
... the top 2 medical affairs teams in the US. How is your team doing? In the past 6 months, the medical affairs teams for two leading HIV treatments reached ... your team compares in Medical Affairs Reputations: HIV. You’ll learn how infectious disease specialists rate the teams for 8 major HIV treatments, whether they’re satisfied ...
May 2016
-
Patient Reported Outcomes: Strategies for market access
US$ 695.00
... ’s Jakafi (ruxolitinib) is seen as a model application of a PRO strategy – what benefits did the company accrue ... Patients Direct. Linda Deal, Patient-Centered Outcomes Assessment (PCOA) Lead, Global Health & Value, Pfizer. Matt Reaney, Head of Patient-Reported Outcomes, Global Health Economics and Outcomes ...
May 2016
-
The Outlook for Wearable Health Tech in Managing Chronic Disease
US$ 695.00
... or a tool? The huge disconnect between 'health grade' (personal fitness based wearables) and 'med tech' grade wearables continues, but what solutions exist ... ? Which chronic diseases will see wearables having the greatest impact? Critical information on the implementation of wearable tech Analysis of 15+ out-of-industry partnerships ...
May 2016
-
Global Migraine Market Report: 2016 Edition
US$ 800.00
... most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is ... (Over the Counter) medications. The report, “Global Migraine Market” analyzes the currently prevailing condition of the market along with its future scope of ...
April 2016
45 pages
Global Thalassemia Market Report: 2016 Edition
US$ 800.00
... treatments and unmet market of the Asia-Pacific. The report provides a comprehensive study of global thalassemia market and also major regional markets. Furthermore, market dynamics such as key ...
April 2016
45 pages
Oxygen Therapy Market Analysis By Product (Oxygen Source Equipment, Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery Device, Masks, Nasal Cannula, Venturi Mask, Non Rebreather Mask, Bag Valve, CPAP), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia), By End-use (Home Healthcare, Hospitals), And Segment Forecasts To 2024
US$ 4,250.00
... needs pertinent to COPD treatment, thereby propelling the demand for oxygen therapy market Home Healthcare is anticipated to grow lucratively at CAGR of 11.8% owing to associated benefits ...
April 2016
92 pages
Global Depression Treatment Market Research and Analysis, 2014-2020
US$ 3,495.00
Global depression treatment market is facing stiff decline. The market is expected to grow at low CAGR of 1% for the forecasted period of ... are the leading markets. They make up for 70% of the total depression treatment market. The markets are driven by high awareness regarding depression and availability of ...
April 2016
140 pages
Healthcare Integration Market by Product (Interface Engine, Medical Device Integration, Media Integration), by Service (Implementation, Support, Training), by Application (Hospital, Laboratory, Radiology, Clinics) - Global Forecast to 2021
US$ 3,390.00
... healthcare IT integration market growth. In this report, the healthcare IT integration market is segmented based on solutions, applications, and regions. Based on solutions, the market is segmented into products and services. The healthcare integration products market is further bifurcated into interface/integration ...
April 2016
161 pages
Competitor Analysis: CD19-Targeted Therapeutics - 2016 Update
US$ 350.00
Competitor Analysis: CD19-Targeted Therapeutics – 2016 Update This Competitive Intelligence report about CD19-Targeted Therapeutics provides a competitor evaluation in the field of antibody- and T-cell-based therapeutics for the treatment ... T-cells targeting CD19. In addition, the report lists company-specific R&D pipelines of CD19-Targeted Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism ...
April 2016
74 pages
Epiomic Epidemiology Series: Glaucoma Forecast in 10 Major Markets 2016-2026
US$ 6,382.00
... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Glaucoma include: ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used ...
April 2016
48 pages
Epiomic Epidemiology Series: Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026
US$ 6,382.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Tay-Sachs disease prevalent population. Identify sub-populations within Tay-Sachs disease which require treatment ...
April 2016
36 pages
